Raymond James Financial’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2M Buy
422,761
+105,327
+33% +$4.11M 0.01% 1484
2026
Q1
$9.98M Sell
317,434
-10,771
-3% -$334K ﹤0.01% 2026
2025
Q4
$9.14M Sell
328,205
-118,720
-27% -$3.56M ﹤0.01% 2046
2025
Q3
$13.4M Sell
446,925
-7,492
-2% -$211K ﹤0.01% 1697
2025
Q2
$13M Buy
454,417
+24,935
+6% +$742K ﹤0.01% 1677
2025
Q1
$14.2M Buy
429,482
+2,060
+0.5% +$67.2K 0.01% 1551
2024
Q4
$12.3M Buy
+427,422
New +$12.3M ﹤0.01% 1676

Other funds holding ALKS

Raymond James Financial's ALKS Position: Q2 2026 in Review

Raymond James Financial increased its Alkermes (ALKS) stake by 33% in Q2 2026, buying an estimated $4.11M and bringing the position to 422,761 shares worth $22.2M. The position accounts for 0.01% of the portfolio, ranked #1484.

Raymond James Financial first reported a position in ALKS in Q4 2024 and has held it in 7 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Raymond James Financial held 422,761 shares of Alkermes worth $22.2M as of Q2 2026.
  • Raymond James Financial bought 105,327 Alkermes shares in Q2 2026, an estimated $4.11M.
  • Alkermes made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1484 holding.
  • Raymond James Financial first reported a position in Alkermes in Q4 2024 and has held it in 7 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.